This story was originally published here.
It’s pretty hard to ignore the impact of Covid-19 on the global and domestic economy. But the shutdown in the U.S. economy, while swift, was also swiftly managed by the administration and Congress, as well as the Federal Reserve. This has helped buoy the markets after a precipitous initial drop. And it has allowed enough time for investors to process everything that has happened and reset their expectations — looking away from certain risks and into cleaning-supply companies and biotech stocks.
Previous to Covid-19, there was the feeling the economy was nearing recession sometime this year. Now we’re in one.
However, this remains an uneven market. Big stocks like Amazon (NASDAQ:AMZN) and Netflix (NASDAQ:NFLX) are doing even better under these difficult conditions. But other consumer stocks aren’t.
That’s why I wanted to talk about an opportunity that doesn’t have to do with consumer-driven stocks — the seven beautiful biotech stocks to buy here. These companies are set up to endure long drug approval processes that happen over good times and bad.
They’re built to be immune from general market forces, especially the big one these days — consumer spending — and to benefit from powerful technology that’s popping up in all kinds of industries.
Biotech Stocks to Buy: CRISPR Therapeutics (CRSP)
CRISPR is a Swiss biotech that is one of the leaders in CRISPR technology. This is a new and fast-growing field. CRISPR (it stands for clustered regularly interspaced short palindromic repeats) is a DNA segment containing short repetitions of base sequences.
By using these, scientists are learning to identify where there is a break in the pattern that may signal a disease and then repair (or edit) that sequence. This is a revolutionary concept in treating disease, since it is the first step toward personalized medicine.
Currently the research is hoping to build treatments to help battle many different cancers and other diseases. But eventually the technology can be applied to a much broader field of needs.
The company is well funded and will continue to make a difference, even sequencing Covid-19.
The stock is up 37% in the past year and over 30% in the past month.
Editor's Note: To see the other 6 biotech plays, click here.
#1 5G Stock To Buy Now
There’s a lot of hype surrounding 5G these days…
And for good reason. It’s a breakthrough technology that’s going to change the world and make early investors a fortune.
But investing legend Louis Navellier says there’s only one 5G stock you should be paying attention to right now.
This is coming from the analyst who…
- Found Microsoft when it was trading for 39 cents.
- Cisco at 50 cents.
- Qualcomm at $2.45.
- Adobe at $1.91.
- Apple when the legendary software company was trading for $1.38.
- Amazon when it was just a $46 stock (today it’s over $1,885).
And MarketWatch said he was “the advisor who recommended Google before anyone else.”
Now Louis’s pounding the table on a 5G stock he recently uncovered.
He’s put together a presentation with the full details which you can view right here.
